Collaborations, Competitor News

Foundation Medicine Announces Collaboration with Merck KGaA, Darmstadt, Germany to Develop Companion Diagnostics for Selected Marketed and Pipeline Treatments

Posted on

June 05, 2023 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, today announced that it has entered a strategic collaboration with Merck KGaA, Darmstadt, Germany to develop FoundationOne®Liquid CDx and FoundationOne®CDx as companion diagnostics in the U.S. market for selected marketed…

Competitor News, HR

Komodo Health Appoints Vikas Mehta as Chief Financial Officer; Names Sarah Shin as Chief People Officer

Posted on

New Executive Appointments Bolster Komodo’s Seasoned Leadership Team as It Exceeds $200M in Annual Recurring Revenue in Fiscal Year 2023, Signaling Continued Business Momentum Vikas Mehta, Chief Financial Officer, Komodo Health (Photo: Business Wire) June 05, 2023 08:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Komodo Health, a leading healthcare technology…

Government/Regulatory, Partner and Collaborator News

US Special Operations Command Awards Contract to Palantir

Posted on

DENVER, June 5, 2023 /PRNewswire/ — Palantir Technologies Inc. (NYSE: PLTR) today announced it was awarded a contract from the US Special Operations Command (USSOCOM) to deliver technology solutions to support enterprise capabilities. The multi-year contract is worth up to $463 million.  Palantir provides best in class software capabilities for America’s warfighters, including the men…

Collaborations, Competitor News, Oncology

Foundation Medicine Announces Collaboration with Merck KGaA, Darmstadt, Germany to Develop Companion Diagnostics for Selected Marketed and Pipeline Treatments

Posted on

June 05, 2023 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, today announced that it has entered a strategic collaboration with Merck KGaA, Darmstadt, Germany to develop FoundationOne®Liquid CDx and FoundationOne®CDx as companion diagnostics in the U.S. market for selected marketed…

Competitor News, Oncology, Product Updates

Foundation Medicine Expands Monitoring Portfolio with Launch of FoundationOne®Monitor

Posted on

June 02, 2023 07:05 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., today announced the launch of its tissue-naïve circulating tumor DNA (ctDNA) monitoring assay, FoundationOne®Monitor, for research use in retrospective studies. Currently available for biopharma customers, FoundationOne Monitor provides unique access to Foundation Medicine’s ctDNA tumor fraction biomarker…

Academic, Collaborations, Competitor News, Data Partnership, Oncology

Aster Insights announces that The University of Kansas Cancer Center will join the Oncology Research Information Network (ORIEN)

Posted on

Leading academic cancer research network led by Aster Insights accelerates oncology discovery and therapeutic development TAMPA, Fla. and KANSAS CITY, Kan., June 2, 2023 /PRNewswire/ — Aster Insights, the leading provider of technology-enabled data and analytics solutions for oncology discovery, today announced The University of Kansas Cancer Center will join its Oncology Research Information Exchange Network (ORIEN). The…

Blogs/Publications, Competitor News, Marketing, RWE Study

Journal of Otolaryngology Study Finds Surgical Treatment of Sleep Apnea More Effective than CPAP Therapy in Preventing the Onset of Type 2 Diabetes

Posted on

CAMBRIDGE, Mass., June 1, 2023 /PRNewswire/ — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Quirónsalud Marbella and Hospital Campo de Gibraltar to leverage European and global real-world data (RWD) for a study that found patients diagnosed with sleep apnea have a lower…

China, Collaborations, Competitor News, International

EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally

Posted on

BEIJING, June 1, 2023 /PRNewswire/ — EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today announced that it has established a strategic alliance with the China Resources Pharmaceutical Commercial Group, a leading pharmaceutical distribution enterprise based in Beijing. Together, the two organizations will collaborate on helping expand access to…

Collaborations, Competitor News, Data Partnership, Oncology

Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform

Posted on

IRVING, Texas and CAMBRIDGE, Mass., June 1, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, and ConcertAI, the leading oncology real-world evidence data and AI technology company, today announced an expanded translational sciences and clinical development solutions…